Tag Archives: Merck pill breakthrough raises hopes of preventing virus deaths

WASHINGTON: A pill developed by US drugmaker Merck could halve the chances of dying or being hospitalised for those most at risk of contracting severe Covid-19, with experts hailing it as a potential breakthrough in how the virus is treated. If it gets authorisation, molnupiravir, which is designed to introduce errors into the genetic code of the virus, would be …

Read More »